Title: WESTERN STATES MEDICAL AND OTHER PROBLEMS WITH THE DOCTRINE CONCERNING FDA REGULATION OF COMMERCIAL SPEECH (2003 Third Year Paper)
Author(s): Brian Kang
Subject & Subject keywords: Food and Drug Law "" "commercial speech" "" "free speech" "" "regulation" "" "First Amendment"
Abstract:This paper will attempt to explain the current state of how commercial speech doctrine affects FDA regulation by looking closely to a recently decided case: Thompson v. Western States Medical. This case will then be used as platform from which to critique current commercial speech doctrine and suggest changes. This paper will then turn to other recent developments in the law, both in caselaw and legal scholarship, which may have profound effects on how we think about commercial speech.

PDF version (suitable for printing)

Kang.pdf (complete document)

HTML version (suitable for viewing with web browser)

Kang.html (complete document)

Rich Text Format version (suitable for use with word processor)

Kang.rtf (complete document)

ZIP'ped version (suitable for downloading)

HLS.Library.Leda/kangb-western_states_medical

Depositors authorize the Legal Information Institute to retain in perpetuity a digital copy of their scholarship and to provide, without charge, individual users of LEDA with the ability to view or print copies of a LEDA document for private, non-commercial use. Authors retain all other rights, including the rights of subsequent publication.